DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $778,797 | -9.8% | 3,541,393 | -1.6% | 1.06% | -0.4% |
| Q2 2023 | $863,524 | +14.8% | 3,598,030 | +20.6% | 1.06% | +7.9% |
| Q1 2023 | $751,904 | -2.2% | 2,983,285 | +3.0% | 0.98% | -7.0% |
| Q4 2022 | $769,091 | -99.9% | 2,897,649 | +2.2% | 1.06% | -1.0% |
| Q3 2022 | $732,247,000 | +0.9% | 2,834,988 | -1.0% | 1.07% | +9.0% |
| Q2 2022 | $726,042,000 | -6.4% | 2,863,855 | +8.3% | 0.98% | +9.4% |
| Q1 2022 | $775,345,000 | -10.5% | 2,643,264 | +0.4% | 0.90% | -2.6% |
| Q4 2021 | $866,438,000 | +7.1% | 2,633,474 | -0.9% | 0.92% | +1.0% |
| Q3 2021 | $809,046,000 | +13.4% | 2,657,497 | -0.0% | 0.91% | +14.0% |
| Q2 2021 | $713,318,000 | +18.9% | 2,658,073 | -0.3% | 0.80% | +10.3% |
| Q1 2021 | $599,800,000 | +1.3% | 2,664,838 | +0.0% | 0.73% | -2.9% |
| Q4 2020 | $591,858,000 | -0.8% | 2,664,356 | -3.8% | 0.75% | -10.7% |
| Q3 2020 | $596,532,000 | +9.9% | 2,770,326 | -9.8% | 0.84% | +0.4% |
| Q2 2020 | $542,913,000 | +33.6% | 3,070,270 | +4.6% | 0.84% | +12.2% |
| Q1 2020 | $406,231,000 | -9.7% | 2,934,999 | +0.1% | 0.74% | +15.9% |
| Q4 2019 | $449,847,000 | +18.7% | 2,930,992 | +11.7% | 0.64% | +3.0% |
| Q3 2019 | $379,068,000 | -4.0% | 2,624,597 | -5.0% | 0.62% | -2.7% |
| Q2 2019 | $394,954,000 | -6.3% | 2,763,477 | -13.4% | 0.64% | -7.1% |
| Q1 2019 | $421,424,000 | +40.3% | 3,192,133 | +9.6% | 0.69% | +24.6% |
| Q4 2018 | $300,403,000 | -6.4% | 2,913,156 | -1.4% | 0.55% | +6.6% |
| Q3 2018 | $321,096,000 | +43.2% | 2,955,076 | +30.1% | 0.52% | +33.1% |
| Q2 2018 | $224,219,000 | +53.1% | 2,272,216 | +51.9% | 0.39% | +56.0% |
| Q1 2018 | $146,477,000 | +447.3% | 1,496,058 | +418.9% | 0.25% | +443.5% |
| Q4 2017 | $26,762,000 | +78611.8% | 288,331 | +71982.8% | 0.05% | – |
| Q3 2017 | $34,000 | +3.0% | 400 | 0.0% | 0.00% | – |
| Q2 2017 | $33,000 | -2.9% | 400 | 0.0% | 0.00% | – |
| Q1 2017 | $34,000 | -85.9% | 400 | -84.6% | 0.00% | -100.0% |
| Q4 2015 | $241,000 | +66.2% | 2,600 | +52.9% | 0.00% | – |
| Q4 2014 | $145,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |